Abeona Therapeutics
ABEO
104 hedge funds and large institutions have $205M invested in Abeona Therapeutics in 2025 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 37 increasing their positions, 31 reducing their positions, and 18 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
143% more call options, than puts
Call options by funds: $8.88M | Put options by funds: $3.65M
22% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 18
19% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 31
9% more capital invested
Capital invested by funds: $188M → $205M (+$17.3M)
4% more funds holding
Funds holding: 100 → 104 (+4)
2.45% more ownership
Funds ownership: 69.4% → 71.85% (+2.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$10.1M |
| 2 |
CCC
Cable Car Capital
San Francisco,
California
|
+$9.56M |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
+$5.03M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.53M |
| 5 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$3.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$16.1M |
| 2 |
WSL
Western Standard LLC
Los Angeles,
California
|
-$6.6M |
| 3 |
BCM
Boone Capital Management
Atlanta,
Georgia
|
-$2.66M |
| 4 |
Renaissance Technologies
New York
|
-$2.07M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$2.04M |
ABEO Hedge Fund Activity: Q4 2025 in Review
104 of the 8,270 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q4 2025, worth a combined $205M — up 9.2% from $188M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new ABEO positions and 18 closed out — a net gain of 4 holders — while 37 added to existing stakes and 31 trimmed.
The largest buyer was AIGH Capital Management, opening a new position worth an estimated $10.1M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $16.1M sold.
- 104 institutional investors held Abeona Therapeutics (ABEO) as of Q4 2025, up from 100 in Q3 2025.
- Funds reported $205M of Abeona Therapeutics stock for Q4 2025, up 9.2% quarter-over-quarter.
- 22 funds opened new Abeona Therapeutics positions in Q4 2025 and 18 closed out, a net change of +4 holders.
- The largest Abeona Therapeutics buyer in Q4 2025 was AIGH Capital Management, an estimated $10.1M added.
- The largest Abeona Therapeutics seller in Q4 2025 was Adage Capital Partners, an estimated $16.1M sold.
Based on aggregated 13F filings for Q4 2025.